These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29253572)

  • 21. Secretory clusterin contributes to oxaliplatin resistance by activating Akt pathway in hepatocellular carcinoma.
    Xiu P; Dong X; Dong X; Xu Z; Zhu H; Liu F; Wei Z; Zhai B; Kanwar JR; Jiang H; Li J; Sun X
    Cancer Sci; 2013 Mar; 104(3):375-82. PubMed ID: 23279642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockage of Stat3 enhances the sensitivity of NSCLC cells to PI3K/mTOR inhibition.
    Jin HO; Lee YH; Park JA; Kim JH; Hong SE; Kim HA; Kim EK; Noh WC; Kim BH; Ye SK; Chang YH; Hong SI; Hong YJ; Park IC; Lee JK
    Biochem Biophys Res Commun; 2014 Feb; 444(4):502-8. PubMed ID: 24472538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
    Shi H; Pu J; Zhou XL; Ning YY; Bai C
    Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of simvastatin on the resistance to EGFR tyrosine kinase inhibitors in a non-small cell lung cancer with the T790M mutation of EGFR.
    Hwang KE; Kwon SJ; Kim YS; Park DS; Kim BR; Yoon KH; Jeong ET; Kim HR
    Exp Cell Res; 2014 May; 323(2):288-96. PubMed ID: 24631288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clusterin modulates transdifferentiation of non-small-cell lung cancer.
    Jin R; Chen X; Han D; Luo X; Li H
    BMC Cancer; 2017 Sep; 17(1):661. PubMed ID: 28954633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of silkworm vacuolar-type ATPase activity by its inhibitor Bafilomycin A1 induces caspase-dependent apoptosis in an embryonic cell line of silkworm.
    Tan XY; Wang X; Liu QS; Xie XQ; Li Y; Li BQ; Li ZQ; Xia QY; Zhao P
    Arch Insect Biochem Physiol; 2018 Nov; 99(3):e21507. PubMed ID: 30246413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clusterin, a Novel DEC1 Target, Modulates DNA Damage-Mediated Cell Death.
    Ming X; Bao C; Hong T; Yang Y; Chen X; Jung YS; Qian Y
    Mol Cancer Res; 2018 Nov; 16(11):1641-1651. PubMed ID: 30002194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of microRNA-21 in radiosensitivity in non-small cell lung cancer cells by targeting PDCD4 gene.
    Jiang LP; He CY; Zhu ZT
    Oncotarget; 2017 Apr; 8(14):23675-23689. PubMed ID: 28423589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-small cell lung carcinoma therapy using mTOR-siRNA.
    Matsubara H; Sakakibara K; Kunimitsu T; Matsuoka H; Kato K; Oyachi N; Dobashi Y; Matsumoto M
    Int J Clin Exp Pathol; 2012; 5(2):119-25. PubMed ID: 22400071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-like growth factor-I receptor signaling pathway induces resistance to the apoptotic activities of SCH66336 (lonafarnib) through Akt/mammalian target of rapamycin-mediated increases in survivin expression.
    Oh SH; Jin Q; Kim ES; Khuri FR; Lee HY
    Clin Cancer Res; 2008 Mar; 14(5):1581-9. PubMed ID: 18316583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apoptotic induction by simvastatin in human lung cancer A549 cells via Akt signaling dependent down-regulation of survivin.
    Hwang KE; Na KS; Park DS; Choi KH; Kim BR; Shim H; Jeong ET; Kim HR
    Invest New Drugs; 2011 Oct; 29(5):945-52. PubMed ID: 20464445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of vacuolar ATPase attenuates the TRAIL-induced activation of caspase-8 and modulates the trafficking of TRAIL receptosomes.
    Horova V; Hradilova N; Jelinkova I; Koc M; Svadlenka J; Brazina J; Klima M; Slavik J; Hyrslova Vaculova A; Andera L
    FEBS J; 2013 Jul; 280(14):3436-50. PubMed ID: 23678861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arctigenin enhances chemosensitivity to cisplatin in human nonsmall lung cancer H460 cells through downregulation of survivin expression.
    Wang HQ; Jin JJ; Wang J
    J Biochem Mol Toxicol; 2014 Jan; 28(1):39-45. PubMed ID: 24395429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteasome inhibition with bortezomib enhances activity of topoisomerase I-targeting drugs by NF-kappaB-independent mechanisms.
    Takigawa N; Vaziri SA; Grabowski DR; Chikamori K; Rybicki LR; Bukowski RM; Ganapathi MK; Ganapathi R; Mekhail T
    Anticancer Res; 2006; 26(3A):1869-76. PubMed ID: 16827119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. sCLU as prognostic biomarker and therapeutic target in osteosarcoma.
    Ma J; Gao W; Gao J
    Bioengineered; 2019 Dec; 10(1):229-239. PubMed ID: 31117872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased production of reactive oxygen species by the vacuolar-type (H(+))-ATPase inhibitors bafilomycin A1 and concanamycin A in RAW 264 cells.
    Yokomakura A; Hong J; Ohuchi K; Oh SE; Lee JY; Mano N; Takahashi T; Hwang GW; Naganuma A
    J Toxicol Sci; 2012; 37(5):1045-8. PubMed ID: 23038011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Luteoloside induces G
    Zhou M; Shen S; Zhao X; Gong X
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Bafilomycin A1: an inhibitor of vacuolar H (+)-ATPases on endocytosis and apoptosis in RAW cells and RAW cell-derived osteoclasts.
    Xu J; Feng HT; Wang C; Yip KH; Pavlos N; Papadimitriou JM; Wood D; Zheng MH
    J Cell Biochem; 2003 Apr; 88(6):1256-64. PubMed ID: 12647307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-mediated epigenetic targeting of Survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancer.
    Wang S; Zhu L; Zuo W; Zeng Z; Huang L; Lin F; Lin R; Wang J; Lu J; Wang Q; Lin L; Dong H; Wu W; Zheng K; Cai J; Yang S; Ma Y; Ye S; Liu W; Yu Y; Tan J; Liu B
    Oncotarget; 2016 Jun; 7(25):37693-37713. PubMed ID: 27177222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.